enGene Therapeutics Inc.
ENGN • NASDAQ • Stock Fundamentals
enGene Therapeutics Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ronald H. W. Cooper, with a market cap of $117.9M.
Market Cap$117.9M
Employees33.0
CEORonald H. W. Cooper
CountryCanada
Healthcare
Biotechnology
Most Recent EarningsMar 9, 2026 · 2 months 19 days agoQ1 2026
View reportNext EarningsJun 11, 2026 · In 2 weeksBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
enGene Therapeutics Inc. FAQ
Common questions about enGene Therapeutics Inc.
enGene Therapeutics Inc. (ENGN) has a market capitalization of $117.9M and trades on NASDAQ.
enGene Therapeutics Inc. has approximately 33 employees.